Association between alcohol intake and health-related quality of life in breast cancer survivors.

S Sanjna Rajput (Mayo Clinic Hospital, Rochester, MN) R Robert A. Vierkant (Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, MN) N Nicole Larson (Mayo Clinic Rochester, Rochester, MN) D Daniela L. Stan (Mayo Clinic, Rochester, MN) D Dawn Mussallem (Mayo Clinic, Jacksonville, FL) S Stacy D. D'Andre (Mayo Clinic, Rochester, MN) F Fergus Couch J Janet E. Olson C Ciara Catherine O'Sullivan (Mayo Clinic Rochester, Rochester, MN) K Kathryn Jean Ruddy (Department of Oncology, Mayo Clinic Rochester, Rochester, MN)

Abstract

11114 Background: Advances in early detection and treatment of breast cancer (BC) have significantly improved survival outcomes. In this growing survivor population, addressing modifiable lifestyle factors such as alcohol intake (AI), a known risk factor for BC and BC recurrence, is critical to improving prognosis and health-related quality of life (HRQoL). This study examines AI patterns and their associations with mental and physical HRQoL in early BC survivorship. Methods: Adult patients newly diagnosed (≤1 year) with stage I–III BC at Mayo Clinic Rochester were invited to enroll in the Mayo Clinic Breast Disease Registry. Of the 3252 patients who consented, 1997 completed surveys approximately one-year post-diagnosis, capturing weekly AI, demographic factors, and PROMIS-10 scores. PROMIS-10 (a 10-item measure of health, well-being, and distress) physical and mental health T-scores (mean = 50, SD = 10) are standardized to the U.S. population. Weekly AI was categorized as minimal/none (<1 drink), mild (1–4 drinks), moderate (5–14 drinks), or high (≥15 drinks). Univariate analyses were performed with Monte Carlo-based Fisher exact tests. Multivariate multinomial logistic regression models using a glogit link function assessed AI as the outcome and PROMIS-10 scores as independent variables, adjusting for financial status, smoking, chemotherapy, and moderate exercise because those were associated with AI at year 1 in prior analyses. Results: Univariate analyses revealed statistically significant associations between AI and PROMIS-10 scores (Table 1). Adjusted multivariate analyses identified that patients with better physical health were more likely to drink 1–4 or 5–14 drinks/week and less likely to abstain (<1 drink/week) than those with poorer physical health (p=0.027). There was no statistically significant association between AI and mental health QoL after adjustment for covariates. Conclusions: Better physical HRQoL during early survivorship was associated with higher AI, suggesting that patients who are feeling physically unwell may be less likely to drink alcohol. Additional public health messaging about the relationship between AI and breast cancer risk and recurrence may be needed, especially for those who are feeling well enough to consume alcohol. Univariate analyses of year 1 PROMIS-10 scores with year 1 alcohol consumption using Monte Carlo-based Fisher exact test. Alcoholic drinks per week at year 1 < 1(N=1204) 1-4(N=600) 5-14(N=175) 15+(N=18) Total(N=1997) P-value PROMIS global mental health T score, Year 1, n (%) 0.008 < 50 466 (63.8%) 200 (27.4%) 54 (7.4%) 10 (1.4%) 730 (37.1%) 50+ 718 (57.9%) 394 (31.8%) 120 (9.7%) 7 (0.6%) 1239 (62.9%) Missing 20 6 1 1 28 PROMIS global physical health T score, Year 1, n (%) <0.001 < 50 440 (66.5%) 165 (24.9%) 50 (7.6%) 7 (1.1%) 662 (33.6%) 50+ 740 (56.7%) 432 (33.1%) 124 (9.5%) 10 (0.8%) 1306 (66.4%) Missing 24 3 1 1 29

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 11114-11114
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (10)

S

Sanjna Rajput

Mayo Clinic Hospital, Rochester, MN

R

Robert A. Vierkant

Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, MN

N

Nicole Larson

Mayo Clinic Rochester, Rochester, MN

D

Daniela L. Stan

Mayo Clinic, Rochester, MN

D

Dawn Mussallem

Mayo Clinic, Jacksonville, FL

S

Stacy D. D'Andre

Mayo Clinic, Rochester, MN

F

Fergus Couch

J

Janet E. Olson

C

Ciara Catherine O'Sullivan

Mayo Clinic Rochester, Rochester, MN

K

Kathryn Jean Ruddy

Department of Oncology, Mayo Clinic Rochester, Rochester, MN